Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome

被引：1

作者：

Altermanini, Mohammad ^{[1
]}

Habib, Mhd Baraa ^{[1
]}

Alkhiyami, Dania ^{[2
]}

Ali, Khaled ^{[3
]}

Abdelghani, Mohamed Salah ^{[4
]}

Hamamyh, Tahseen ^{[4
]}

Elyas, Ahmad ^{[4
]}

Elhassan, Mawahib ^{[4
]}

机构：

[1] Hamad Med Corp, Dept Internal Med, Doha, Qatar

[2] Hamad Med Corp, Doha, Qatar

[3] Hamad Med Corp, Community Med Dept, Doha, Qatar

[4] Hamad Med Corp, Heart Hosp, Dept Cardiol, Doha, Qatar

来源：

HELIYON | 2023年 / 9卷 / 08期

关键词：

Brugada; Coronavirus; COVID-19; Vaccine; BNT162b2; Syncope; COMMON;

D O I：

10.1016/j.heliyon.2023.e18716

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The Brugada syndrome is an uncommon inherited condition associated with increased risk of ventricular tachyarrhythmias and sudden cardiac death. Different triggers including fever are well known to precipitate the Brugada pattern on electrocardiogram. We report a patient who presents with syncope, two days after the first dose of the BNT162b2 vaccine due to fever-related unmasking of Brugada syndrome.

引用

页数：4

共 50 条

[1] SYNCOPE FOLLOWING PFIZER-BIONTECH (BNT162B2) VACCINATION UNMASKING BRUGADA SYNDROME
Altermanini, Mohammad
Habib, Mhd Baraa
Hamamyh, Tahseen
Mohamed, Mouhand
Elyas, Ahmed Abdalla
Elhassan, Mawahib
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 3340 - 3340
[2] HYPEREOSINOPHILIC SYNDROME FOLLOWING THE BNT162B2 (BIONTECH / PFIZER) VACCINATION
Hoxha, A.
Tomaselli, T.
Minicuci, G.
Scanelli, G.
Zardo, D.
Naldi, L.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1693 - 1694
[3] Guillain-Barre syndrome following Pfizer-BioNTech (BNT162b2) vaccination: a case report
Chaudhary, Aashutosh
Khadka, Shrekshya
Dulal, Aliza
Adhikari, Rojeena
Bhardwaj, Sushant
Pandey, Abhishek
Chaudhary, Ashlesha
Bhusal, Suzit
Acharya, Smriti
ANNALS OF MEDICINE AND SURGERY, 2024, 86 (11): : 6693 - 6695
[4] Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination
Matsubara, Akihiro
Sakurai, Mai
Morita, Akimichi
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (06) : 187 - 188
[5] Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Hamada, Yohhei
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
[6] Myocarditis Following Pfizer-BioNTech BNT162b2 Vaccine: Epidemiology and Predisposition
Mevorach, Enelle
Tabib, Adi
Mevorach, Dror
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2040 - 2041
[7] Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
Yohhei Hamada
Journal of Pharmaceutical Policy and Practice, 14
[8] A racing heart post-Pfizer/BioNTech BNT162b2
Teo, Hooi Khee
Ho, Kah Leng
Tan, Boon Yew
Ching, Chi Keong
Chong, Daniel Thuan Tee
JOURNAL OF ARRHYTHMIA, 2022, 38 (05) : 827 - 830
[9] Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
Navas, Leandra J. Robles
Huete, Juan J. Ortega
Sanchis, Maria L. Julia
Miro, Jorge S. Bravo
Sanchez, Serezade Cervera
Gasset, Ricardo Molina
ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 298 - 302
[10] Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination
Algaissi, Abdullah
Alamer, Edrous
Jeraiby, Mohammed
Alomaish, Abeer
Elrhima, Omer
Qumayi, Sultan
Qasir, Naaif A.
Areeshi, Halima
Masmali, Asma
Alhazmi, Abdulaziz
SAUDI MEDICAL JOURNAL, 2022, 43 (06) : 567 - 571

← 1 2 3 4 5 →